HCG 23 Day Injection Extra Strength — Class II drug recall D-1153-2019
Terminated recall by Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy, reported 2019-04-24, distributed nationwide. Lack of sterility assurance.
| Recall number | D-1153-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy, Bristol, TN, United States |
| Recall initiated | 2019-04-02 |
| Classified | 2019-04-18 |
| Reported by FDA | 2019-04-24 |
| Terminated | 2021-09-24 |
| Distributed | Nationwide (US) |
| Quantity | 14 vials |
| Reason classes | sterility |
Product
HCG 23 Day Injection Extra Strength, vials, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN 1-800-263-8890
Reason for recall
Lack of sterility assurance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1153-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.